8-K - Virpax Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Charter Amendment

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.03

. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On March 12, 2025, Virpax Pharmaceuticals, Inc. (the “Company”) filed a Certificate

Charter Amendment

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation, f

Exhibits Only

Exhibits (2)

3.1

EXHIBIT 3.1

8-K

FORM 8-K